- Home
- CPRX vs GRBK Comparison
CPRX vs GRBK Comparison
Compare CPRX & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- GRBK
- Stock Information
- Founded
- CPRX 2002
- GRBK N/A
- Country
- CPRX United States
- GRBK United States
- Employees
- CPRX N/A
- GRBK N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- GRBK Homebuilding
- Sector
- CPRX Health Care
- GRBK Consumer Discretionary
- Exchange
- CPRX Nasdaq
- GRBK Nasdaq
- Market Cap
- CPRX 2.6B
- GRBK 2.9B
- IPO Year
- CPRX 2006
- GRBK N/A
- Fundamental
- Price
- CPRX $19.83
- GRBK $65.16
- Analyst Decision
- CPRX Strong Buy
- GRBK Buy
- Analyst Count
- CPRX 6
- GRBK 2
- Target Price
- CPRX $32.83
- GRBK $71.00
- AVG Volume (30 Days)
- CPRX 1.4M
- GRBK 264.2K
- Earning Date
- CPRX 08-06-2025
- GRBK 07-30-2025
- Dividend Yield
- CPRX N/A
- GRBK N/A
- EPS Growth
- CPRX 183.96
- GRBK 7.68
- EPS
- CPRX 1.65
- GRBK 7.83
- Revenue
- CPRX $558,499,000.00
- GRBK $2,137,742,000.00
- Revenue This Year
- CPRX $16.37
- GRBK N/A
- Revenue Next Year
- CPRX $8.80
- GRBK $12.17
- P/E Ratio
- CPRX $11.91
- GRBK $8.23
- Revenue Growth
- CPRX 28.55
- GRBK 13.87
- 52 Week Low
- CPRX $16.06
- GRBK $50.57
- 52 Week High
- CPRX $26.58
- GRBK $84.66
- Technical
- Relative Strength Index (RSI)
- CPRX 37.75
- GRBK 50.71
- Support Level
- CPRX $19.15
- GRBK $64.29
- Resistance Level
- CPRX $22.53
- GRBK $66.60
- Average True Range (ATR)
- CPRX 0.73
- GRBK 1.79
- MACD
- CPRX -0.03
- GRBK -0.19
- Stochastic Oscillator
- CPRX 24.26
- GRBK 54.87
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.